These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 33271883)

  • 1. Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations.
    Klyachko NL; Arzt CJ; Li SM; Gololobova OA; Batrakova EV
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33271883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
    Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
    Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.
    Claridge B; Lozano J; Poh QH; Greening DW
    Front Cell Dev Biol; 2021; 9():734720. PubMed ID: 34616741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications.
    Surman M; Drożdż A; Stępień E; Przybyło M
    Curr Pharm Des; 2019; 25(2):132-154. PubMed ID: 30848183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging prospects of extracellular vesicles for brain disease theranostics.
    Wang R; Wang X; Zhang Y; Zhao H; Cui J; Li J; Di L
    J Control Release; 2022 Jan; 341():844-868. PubMed ID: 34953980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review.
    Draguet F; Bouland C; Dubois N; Bron D; Meuleman N; Stamatopoulos B; Lagneaux L
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
    Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
    ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
    Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
    J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinspired extracellular vesicle-coated silica nanoparticles as selective delivery systems.
    Dumontel B; Jiménez-Jiménez C; Vallet-Regí M; Manzano M
    Mater Today Bio; 2023 Dec; 23():100850. PubMed ID: 38024844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.
    Dang XTT; Kavishka JM; Zhang DX; Pirisinu M; Le MTN
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Therapy Empowered by Extracellular Vesicle-Mediated Targeted Delivery.
    Chen Y; Huang Y; Deng Y; Liu X; Ye J; Li Q; Luo Y; Lin Y; Liang R; Wei J; Zhang J; Li Y
    Biol Pharm Bull; 2023; 46(10):1353-1364. PubMed ID: 37779037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicle-Based Hybrid Systems for Advanced Drug Delivery.
    Rodríguez DA; Vader P
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide hydrogel platforms as suitable carriers of liposomes and extracellular vesicles for dermal applications.
    Pourtalebi Jahromi L; Rothammer M; Fuhrmann G
    Adv Drug Deliv Rev; 2023 Sep; 200():115028. PubMed ID: 37517778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered extracellular vesicles as brain therapeutics.
    Lino MM; Simões S; Tomatis F; Albino I; Barrera A; Vivien D; Sobrino T; Ferreira L
    J Control Release; 2021 Oct; 338():472-485. PubMed ID: 34428481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.